" class="no-js "lang="en-US"> Catherine Bianchi, Saint-Gobain, on Pharmaceutical Products
Sunday, March 26, 2023

Breaking News

Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Celyad Oncology Appoints Georges Rawadi as Its New CEO Companion Spine Closes $60.1 Million Series A Funding Round EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer GT Medical Technologies Raises $45 Million in Oversubscribed Series C Financing Led by Gilde Healthcare Genprex CEO Commends FDA’s Initiative to Accelerate Approval Process for Gene Therapies OliX Pharmaceuticals Receives Regulatory Approval to Commence Phase 1 Clinical Trial of Treatment of Androgenic Alopecia Bayer Expands Global Clinical Program for NUBEQA® (darolutamide) in Prostate Cancer BIOTECanada Welcomes Government of Canada’s Strategy on Improving Access to Care for Patients with Rare Diseases

March 8 2023

Catherine Bianchi, Saint-Gobain, on Pharmaceutical Products

In the video, Catherine Bianchi, Marketing Group Leader of Bioprocess Solutions at Saint-Gobain, introduces the products her company is showcasing at the Pharmapack Europe 2023 event. She begins by discussing the company’s single-use systems, including bioprocess bags and tubing, which are used for the storage and transport of biological materials.

Bianchi highlights the importance of sustainability within the industry and explains how Saint-Gobain’s single-use systems are designed to meet environmental requirements and can be customized to fit specific customer needs.

In conclusion, Bianchi emphasizes the importance of high-quality and reliable single-use systems, tubing, and external components in the biopharmaceutical industry and how Saint-Gobain is committed to providing these products to its customers in line with its sustainability goals.

  1. Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa

    Diseases

     Read more
  2. Celyad Oncology Appoints Georges Rawadi as Its New CEO

    Appointments

     Read more
  3. Companion Spine Closes $60.1 Million Series A Funding Round

    Fundraising

     Read more
  4. EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis

    News

     Read more
  5. Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer

    Appointments

     Read more
More On